Methods and systems for control of gas therapy

• US 8,251,061 B2
• Filed: 08/30/2004
• Issued: 08/28/2012
• Est. Priority Date: 09/18/2003
• Status: Expired due to Fees

• Current Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Original Assignee: Cardiac Pacemakers Incorporated (Boston Scientific Corporation)
• Inventors: Lee, Kent, Hartley, Jesse W., Stahmann, Jeffrey E., Ni, Quan
• Primary Examiner(s): Bianco, Patricia
• Assistant Examiner(s): PATEL, NIHIR B
• Application Number:
  US10/929,306
• Publication Number:
  US 20050061323A1
• Time in Patent Office: 2,920 Days
• Field of Search: 12820418-20423, 128/204.26, 128/205.11, 128/205.23, 128/205.24, 128/203.12, 128/203.22, 128/200.24
• US Class Current: 128/204.23
• CPC Class Codes: A61M 16/00 Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes stimulating the respiratory movement by mechanical, pneumatic or electrical means, iron lungs combined with gas breathing means A61H31/00
• CPC Class Codes: A61M 16/024 including calculation means, e.g. using a processor
• CPC Class Codes: A61M 2016/0039 in the inspiratory circuit
• CPC Class Codes: A61M 2230/04 Heartbeat characteristics, e.g. ECG, blood pressure modulation
• CPC Class Codes: A61M 2230/08 Other bio-electrical signals
• CPC Class Codes: A61M 2230/205 partial oxygen pressure (P-O2)
• CPC Class Codes: A61M 2230/63 Motion, e.g. physical activity

Abstract

A gas therapy system involves sensing the blood gas concentration of the patient and adapting a gas therapy based on the sensed gas concentration. Disordered breathing may be detected bases on blood gas concentration, and gas or cardiac electrical therapy may be adapted to treat the detected disordered breathing. One or more of sensing the blood gas concentration, detecting disordered breathing, or adapting the therapy may be performed at least in part implantably. The gas therapy is delivered to the patient through an external respiratory device, such as a positive airway pressure device.

Claims

1. A therapy method, comprising:

controlling delivery of a gas therapy delivered by a gas therapy delivery unit to a patient'"'"'s pulmonary system, the gas therapy involving delivery of a first gas;

sensing concentration of a blood gas;

detecting a disorder based on the blood gas concentration; and

adapting the gas therapy by modifying delivery of a second gas, different from the first gas, to treat the detected disorder,

wherein at least one of sensing the blood gas concentration and adapting the gas therapy is performed at least in part implantably by a cardiac rhythm management device having a therapy controller, and wherein the therapy controller is wirelessly coupled to the gas therapy delivery unit.

2. The method of claim 1, wherein both of sensing the blood gas concentration and adapting the gas therapy are performed at least in part implantably.

3. The method of claim 1, wherein the disorder comprises disordered breathing.

4. The method of claim 1, wherein:

the disorder comprises disordered breathing; and

the second gas comprises carbon dioxide.

5. The method of claim 4, further comprising:

discerning a type of the detected disordered breathing;

wherein adapting the gas therapy comprises adapting the gas therapy responsive to the disordered breathing type.

6. The method of claim 5, further comprising

discerning the type of disordered breathing comprises discerning central apnea from obstructive apnea.

7. The method of claim 6, wherein adapting the gas therapy comprises applying the carbon dioxide to the patient'"'"'s system through a positive airway pressure device if the disordered breathing type is central apnea.

8. The method of claim 1, wherein adapting the gas therapy comprises increasing or decreasing a pressure of the first gas during adapted gas therapy delivery.

9. The method of claim 1, wherein adapting the gas therapy comprises one or more of introducing, terminating, or adjusting concentration of the first fed through a positive airway pressure device.

10. The method of claim 1, wherein:

detecting the disorder comprises detecting hypoxemia; and

adapting the gas therapy comprises initiating introduction of oxygen to the patient'"'"'s pulmonary system to treat the hypoxemia.

11. The method of claim 1, wherein:

the detected disorder comprises hypocapnia and the adapted gas therapy is delivered to treat the hypocapnia.

12. The method of claim 1, wherein:

the detected disorder comprises ischemia and

the adapted gas therapy is delivered to treat the ischemia.

13. The method of claim 12, wherein the implantable cardiac rhythm management device delivers a cardiac electrical therapy to treat the ischemia.

14. The method of claim 1, wherein the second gas comprises a vasodilator or a bronchodilator.

15. A gas therapy system, comprising:

a sensor configured to sense concentration of a blood gas;

a detector configured to detect a disorder based on the concentration of blood gas;

a therapy controller coupled to the sensor and configured to control delivery of a gas therapy involving a first gas, and to adapt the gas therapy by modifying delivery of a second gas, different from the first gas to treat the detected disorder;

a gas therapy delivery unit coupled to the therapy controller and configured to deliver the adapted gas therapy to the patient'"'"'s pulmonary system; and

an implantable cardiac rhythm management device;

wherein at least one of the sensor and the controller comprises an implantable component coupled to the implantable cardiac rhythm management device, and wherein the therapy controller is wirelessly coupled to the gas therapy delivery unit.

16. The gas therapy system of claim 15, wherein each of the sensor and the therapy controller comprises an implantable component.

17. The gas therapy system of claim 15, wherein the implantable cardiac rhythm management device is an implantable cardiac therapy device, and the sensor is a component of the implantable cardiac therapy device.

18. The gas therapy system of claim 15, wherein the sensor is a component of a patient-external respiratory therapy device.

19. The gas therapy system of claim 15, wherein the sensor is a component of a positive airway pressure device.

20. The gas therapy system of claim 15, wherein the sensor comprises one or both of a blood oxygen sensor or a carbon dioxide sensor.

21. The gas therapy system of claim 15, wherein the implantable cardiac rhythm management device is an implantable cardiac therapy device, and the sensor comprises one or both of an implantable blood oxygen sensor or an implantable carbon dioxide sensor coupled to the implantable cardiac therapy device.

22. The gas therapy system of claim 15, wherein the sensor is wirelessly coupled to the therapy controller.

23. The gas therapy system of claim 15, wherein the sensor is coupled to the controller through the gas therapy delivery unit.

24. The gas therapy system of claim 15, wherein the gas therapy delivery unit comprises one or both of a vasodilating agent delivery arrangement or a bronchodilator agent delivery arrangement.

25. A therapy system, comprising:

means for sensing concentration of a blood gas;

means for determining a disorder of the patient based on the concentration of the blood gas;

means for controlling delivery of a gas therapy comprising a first gas and for adapting the gas therapy, responsive to the detected disorder, by controlling delivery of a second gas, different from the first gas;

means for delivering the adapted gas therapy to a patient by delivering a gas to the patient'"'"'s pulmonary system,

wherein at least one of the sensing means and the adapting means comprises an implantable component, and wherein the means for controlling the gas therapy is wirelessly coupled to the means for delivering the adapted gas therapy.

26. The therapy system of claim 25, wherein the detected disorder is disordered breathing and the second gas comprises carbon dioxide.

27. The therapy system of claim 25, wherein the second gas comprises a vasodialation or bronchiodialation agent.